Low-Cost Drugs Still Relevant in the Present-Day Era

##plugins.themes.bootstrap3.article.main##

  •   Subhashchandra Daga

Abstract

Escalating medical costs contribute to poverty in countries with low resources. The drug costs account for 17 percent of medical expenses. Revisiting time-tested, cost-effective drugs can reduce these costs. Some of them find a place in the WHO Model List of Essential Medicines for Children. The list consists of medicines for a basic healthcare system. They are safe and cost-effective. The present paper identifies co-trimoxazole and chloramphenicol as antimicrobials, chloroquine for malaria, adrenaline, theophylline for asthma, and phenobarbital as an anti-epileptic drug that merits consideration for reviving interest in them and reduce drug treatment costs.


What is already known about this subject?


•       The cost of drugs contributes to rising medical costs.


•       Medical expenses push a large population below the poverty line.


What does this study add?


•       Rediscovering the relevance of old low-cost drugs is essential.


•       Revisiting the WHO Model List of Essential Medicines for Children may be useful.


•       Drugs such as chloramphenicol and theophylline are such examples.


 


Keywords: Low-cost drugs, Medical costs, medical expenses, medical treatment and poverty, WHO essential drugs list

References

Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: Origins and prospects for reform. JAMA. 2016; 316(8): 858–871.

Medical costs push millions of people into poverty across the globe. [Online] Available from: https://www.who.int/mediacentre/news/releases/previous/en.

Medical debt pushed 55 million Indians into poverty in one year. [Online] Available from: https://thelogicalindian.com/story-feed/awareness/medical-debt-pushed-million-indians-poverty/?infinitescroll=1.

WHO model list of essential medicines for children? Fifth list. [Online] 2015. Available from: https://www.who.int/medicines/publications/essentialmedicines/en/.

The management of acute respiratory infection in children. World Health Organization, Geneva, 1995.

Winberg GA. Occult bacteremia. [Online] Available from: https://www.msdmanuals.com/en-gb/home/children-s-health-issues/bacterial-infections-in-infants-and-children/occult-bacteremia.

Leblebicioglu H, Ozaras R, Sunbul M. Role of co-trimoxazole for urinary tract infections in developing countries. Lancet Infectieous Disease. 2015; 15: 764-65.

Christie CDC, Heikens GT, Gold MHN. Coagulase-negative staphylococcal bacteremia among severely malnourished Jamaican children. The Pediatric Infectious Disease Journal. 1992; 11: 1030-36.

Bishara J, Pitlik S, Samra Z, Levy I, Paul M, Leibovici L. Co-trimoxazole–sensitive, methicillin-resistant staphylococcus aureus, Israel, 1988–1997. Emerging Infectious Diseases. 2003; 9(9): 1168–1169.

Daga SR, Patil VB, Verma B. Syndromic management of prolonged fever: a cost-effective approach. Tropical Doctor. 2005; 35: 31-34.

Revised WHO classification and treatment of childhood pneumonia at health facilities. World Health Organization, 2014.

Eliakim-Raz N, Lador A, Leibovici-Weissman Y, Elbaz M, Paul M, Leibovici L. Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy. 2015; 70: 979–996.

Ndu IK, Asinobi IN, Ikwochi U, Amadi OF. Discharge against medical advice (DAMA) among the paediatric age group in Enugu State University Teaching Hospital Parklane, Enugu. Journal of Experimental Research. 2016; 4(1).

Chloramphenicol. In Meyler's Side Effects of Drugs (Sixteenth Edition), 2016.

Guidelines for treatment of malaria, 3rd edition, World Health Organization 2015.

Malaria-World Health Organization. [Online] Available from: http://www.who.int/malaria/publications/world-malariareport-20156/en/.

Chloroquine and hydroxychloroquine. In Meyler's Side Effects of Drugs (Sixteenth Edition), 2016.

WHO /Fact Sheet: World Malaria Report 2015.

Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, et al. Return of chloroquine antimalarial efficacy in Malawi. New England Journal of Medicine. 2006; 355: 1959-66.

Indinnimeo L, Chiappini E, Miraglia del Giudice M. Guideline on management of the acute asthma attack in children by the Italian Society of Pediatrics. Italian Society of Pediatrics. 2018; 44(1): 46.

Becker AB, Nelson NA, Simons FE. Inhaled salbutamol (albuterol) vs. injected epinephrine in the treatment of acute asthma in children. Journal of Pediatrics. 1983; 102: 465-469.

Singhi S, Mathew JL, Torzillo P. What is the role of subcutaneous adrenaline in the management of acute asthma? [Online] 2006. Available from: www.ichrc.org.

Gong W, Jiang J, Fan H. The role of hypodermic injection with a low dose of adrenaline in the emergency treatment of severe asthma. Pharmaceutical Bioprocessing. 2018; 6(3).

Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in bronchi in mild asthma and after bronchial provocation American Review of Respiratory Disease. 1989; 139: 806-817.

Giraud V, N. Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. European Respiratory Journal. 2002; 19: 246-251.

Lee-Wong M, Mayo PH. Results of a programme to improve house staff use of metered-dose inhalers and spacers. Postgraduate Medical Journal. 2003; 79: 221-5.

Sullivan P, Beziers, Zaffar Z, Page C, Jeffery P, Costello J. Anti-inflammatory effects of low dose oral theophylline in atopic asthma. Lancet. 1994, 343: 1006-08.

Hendele S, Weinberger M, Szeflers P, Ellis E. Safety and efficacy of theophylline in children with asthma. Journal of Pediatrics. 1992; 120: 177-83.

Daga S, Verma B, Mhapankar A, Kulkarni S, Kamble P. Theophylline in chronic asthma: A "before and after" study. The Internet Journal of Pediatrics and Neonatology. 2007; 8(1).

The management of acute respiratory infection in children. World Health Organization, Geneva, 1995.

Kale R. The treatment gaps. Epilepsia. 2002; 43(suppl 6): S31-3.

Kale R, Perucca E. Revisiting phenobarbital for epilepsy. BMJ. 2004; 329: 1199-200.

Banu SH, Jahan M, Koli UK, Ferdousi S, Khan NZ, Neville B. Side-effects of phenobarbital and carbamazepine in childhood epilepsy: a randomized controlled trial. BMJ. 2007; 334(7605).

##plugins.themes.bootstrap3.article.details##

How to Cite
Daga, S. (2021). Low-Cost Drugs Still Relevant in the Present-Day Era. European Journal of Clinical Medicine, 2(6), 10–12. https://doi.org/10.24018/clinicmed.2021.2.6.134